In contrast, a low CD9 expression on sEVs produced by colorectal cancer cells was shown to promote their uptake[47], which could be explained by the inactivating effect of CD9 on ADAM17-mediated adhesion of sEVs with α5β1 integrin on recipient cells. Here, CD9 is linked to colorectal cancer.